|
⚲
|
| Keyboard |
| Julius Knowles | |
|---|---|
| Firm | |
| Address | c/o 20 Bio, Inc 399 Revolution Drive, Suite 999 Cambridge, MA 02145 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| 20 Bio Inc | 021-573557 | Executive Officer | 4.5 M of 6.0 M |
||
| 65 Therapeutics Inc | 021-531309 | Executive Officer | 4.5 M of 5.5 M |
||
| Abcuro Inc | 021-490715 | Director | 120.1 M of 199.5 M |
||
| Proximity Therapeutics Inc | 021-399956 | Director | 11.0 M of 11.0 M |
||
| Abcuro Inc | 021-370229 | Director | 15.5 M of 42.0 M |
||
| Keros Therapeutics Inc | 021-362700 | Director | 56.0 M of 56.0 M |
||
| Abcuro Inc | 021-326332 | Director | 8.0 M of 8.0 M |
||
| Keros Therapeutics Inc | 021-326320 | Director | 11.5 M of 23.0 M |
||
| Tilos Therapeutics Inc | 021-295149 | Director | 3.0 M of 4.0 M |
||
| Abcuro Inc | 021-276135 | Director | 2.2 M of 2.2 M |
||
| Tilos Therapeutics Inc | 021-269922 | Director | 0.8 M of 1.5 M |
||
| Keros Therapeutics Inc | 021-262318 | Director | 11.0 M of 11.0 M |
||
| MASS General Brigham Ventures LLC | |||||
| MASS General Brigham Fund III LP | 021-387984 | Executive Officer | of 250.0 M |
70.5 M | |
| Partners Innovation Fund II LP | 021-274388 | Executive Officer | 66.1 M of 66.1 M |
41.3 M | |